JAMA Network
About The Study: Oral corticosteroid use of more than 90 days per year among individuals with atopic dermatitis was associated with a small increased risk of composite adverse outcomes in this large population-based case-control study. Future investigations are warranted to confirm this potential risk of adverse events (AEs) associated with long-term use of oral corticosteroids for patients with exacerbations of atopic dermatitis, and health care professionals should thoroughly weigh the benefits associated with oral corticosteroids against the observed small risk of AEs, while continuously monitoring for AEs.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
